CME Group Management
Management criteria checks 3/4
CME Group's CEO is Terry Duffy, appointed in Nov 2016, has a tenure of 8.25 years. total yearly compensation is $23.47M, comprised of 8.5% salary and 91.5% bonuses, including company stock and options. directly owns 0.023% of the company’s shares, worth $20.34M. The average tenure of the management team and the board of directors is 5.1 years and 19.7 years respectively.
Key information
Terry Duffy
Chief executive officer
US$23.5m
Total compensation
| CEO salary percentage | 8.5% |
| CEO tenure | 8.3yrs |
| CEO ownership | 0.02% |
| Management average tenure | 5.1yrs |
| Board average tenure | 19.7yrs |
Recent management updates
Recent updates
CME Group: Exchanges And Data Will Keep Growing, And So Could Its Dividend
Dec 30CME Group's Dominance Challenged By Now Operational FMX?
Dec 13CME Group: 5 Reasons Why I Am Bullish
Nov 24Trade On, Cash In: Why CME Group Is My Pick For Income And Growth
Oct 27Do CME Group's (NASDAQ:CME) Earnings Warrant Your Attention?
Oct 23
CME Group: An Attractive Business Relatively Out Of Favor
Oct 15CME Group: An Interesting Option For Every Dividend Investor
Oct 08CME Group: Poised To Benefit From Rate Cuts; Continues To Innovate
Sep 03CME Group Has It All - Growth, Dividend Growth, And Value
Aug 26Down But Not Out: Why CME Group Remains One Of My Favorite Dividend Stocks
Aug 01CME Group Inc.'s (NASDAQ:CME) Price Is Out Of Tune With Earnings
Jul 02CME Group: FMX Market Entry Poses Real Risk
Jul 01CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
Jun 05Looking For (Special) Dividends? CME Group Remains One Of My Best Ideas In Finance
May 25CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
May 21Gunning For CME's Golden Goose
May 01Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results
Apr 26CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty
Apr 15CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates
Mar 27CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
Mar 05CME Group Is One Of My Favorite High-Yielding Stocks Today
Feb 29CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15
Feb 20CME Group: Buying 'The House' Proves A Winning Strategy
Feb 14CME Group: Uncertainty In The World Equals Higher Revenue Growth
Feb 04CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$3b |
| Jun 30 2024 | n/a | n/a | US$3b |
| Mar 31 2024 | n/a | n/a | US$3b |
| Dec 31 2023 | US$23m | US$2m | US$3b |
| Sep 30 2023 | n/a | n/a | US$3b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$3b |
| Dec 31 2022 | US$23m | US$2m | US$3b |
| Sep 30 2022 | n/a | n/a | US$3b |
| Jun 30 2022 | n/a | n/a | US$3b |
| Mar 31 2022 | n/a | n/a | US$3b |
| Dec 31 2021 | US$23m | US$2m | US$3b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$2b |
| Mar 31 2021 | n/a | n/a | US$2b |
| Dec 31 2020 | US$16m | US$2m | US$2b |
| Sep 30 2020 | n/a | n/a | US$2b |
| Jun 30 2020 | n/a | n/a | US$2b |
| Mar 31 2020 | n/a | n/a | US$2b |
| Dec 31 2019 | US$12m | US$2m | US$2b |
| Sep 30 2019 | n/a | n/a | US$2b |
| Jun 30 2019 | n/a | n/a | US$2b |
| Mar 31 2019 | n/a | n/a | US$2b |
| Dec 31 2018 | US$13m | US$2m | US$2b |
Compensation vs Market: Terry's total compensation ($USD23.47M) is above average for companies of similar size in the US market ($USD12.45M).
Compensation vs Earnings: Terry's compensation has been consistent with company performance over the past year.
CEO
Terry Duffy (66 yo)
8.3yrs
Tenure
US$23,468,000
Compensation
Mr. Terrence A. Duffy, also known as Terry, has been Chief Executive Officer and Chairman at CME Group, the world’s leading derivatives marketplace since November 15, 2016. Mr. Duffy is the Chief Executive...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 8.3yrs | US$23.47m | 0.023% $ 20.3m | |
| President & CFO | 1.8yrs | US$2.56m | 0.0047% $ 4.1m | |
| Chief Information Officer | 3yrs | US$3.40m | 0.0075% $ 6.6m | |
| Senior MD & Global Head of Commodities Markets | 15.3yrs | US$3.41m | 0.0097% $ 8.5m | |
| Global Head of Fixed Income | less than a year | US$265.08k | 0.0018% $ 1.6m | |
| Senior MD | less than a year | no data | 0.0027% $ 2.3m | |
| MD & Chief Accounting Officer | 10yrs | no data | 0.0065% $ 5.8m | |
| Managing Director of Investor Relations | no data | no data | no data | |
| Senior MD & General Counsel | 2.3yrs | no data | 0.0020% $ 1.8m | |
| Senior Managing Director of Corporate Marketing & Communications | 18yrs | no data | no data | |
| Senior MD & Chief Human Resources Officer | 17.5yrs | no data | 0.0086% $ 7.6m | |
| Chief Transformation Officer | 5.1yrs | no data | 0.0060% $ 5.3m |
5.1yrs
Average Tenure
56yo
Average Age
Experienced Management: CME's management team is seasoned and experienced (5.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 30.1yrs | US$23.47m | 0.023% $ 20.3m | |
| Independent Director | 17.6yrs | US$323.50k | 0.011% $ 9.9m | |
| Independent Director | 21.8yrs | US$264.08k | 0.0050% $ 4.4m | |
| Independent Director | 23.5yrs | US$273.02k | 0.0047% $ 4.1m | |
| Lead Independent Director | 16.5yrs | US$339.66k | 0.0011% $ 960.0k | |
| Independent Director | 31.1yrs | US$277.08k | 0.0070% $ 6.1m | |
| Independent Director | 28.1yrs | US$258.50k | 0.072% $ 63.4m | |
| Independent Director | 25.1yrs | US$301.08k | 0.022% $ 19.3m | |
| Independent Director | 17.6yrs | US$311.08k | 0.0024% $ 2.1m | |
| Independent Director | 16.8yrs | US$325.08k | 0.0029% $ 2.6m | |
| Independent Director | 5.8yrs | US$301.08k | 0.0012% $ 1.0m | |
| Independent Director | 5.8yrs | US$306.08k | 0.0012% $ 1.0m |
19.7yrs
Average Tenure
70.5yo
Average Age
Experienced Board: CME's board of directors are seasoned and experienced ( 19.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 02:43 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CME Group Inc. is covered by 39 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephen Biggar | Argus Research Company |
| Roger Freeman | Barclays |
| Benjamin Budish | Barclays |